TR-1: Standard form for notification of major holdings LONDON, UNITED KINGDOM / ACCESSWIRE / January 13, 2025 / 1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK ...

Company expands sterile fill-finish services, capacity for biologics development and manufacturing, and more pace logo pace ...

The Global Circulating Fluidized Bed Boilers Market  is expected to increase at a compound annual growth rate (CAGR) of 3.7% ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the UK Biobank Pharma ...

Antag Therapeutics (“Antag” or “the company”), a biopharmaceutical company pioneering novel treatments for obesity, today announced the appointment of Joerg Moeller, MD, PhD, as Chief Executive ...

Regulatory ApprovalFormycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 08.01.2025 / 14:30 CET/CESTThe issuer is solely ...

Stanford University are preparing for a Phase II in Pulmonary Arterial Hypertension (PAH)Kiel, Germany, January 8, 2025 – ...

Boehringer Ingelheim BioXcellence™ and Sutro Biopharma Inc. today announced that they successfully applied Sutro’s ...

MURFREESBORO, TN / ACCESSWIRE / January 8, 2025 / National Health Investors, Inc. (NYSE:NHI) announced a series of changes to the Board of Directors which enhances the Board's ability to provide ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, announces the launch of its high-performance HPV IgG ELISA Kit for the sensitive and specific ...

Danaher Diagnostics LLC and Danaher Ventures LLC, two subsidiaries of Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, announced today that they have formed an ...